Evaluation of Introcan Safety 3 Closed IV Catheter

Incidence and time of occurrence of blood leakage with the closed intravascular catheter Introcan Safety 3 in comparison to Introcan Safety

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patients in Need for Intravenous Access

Sex eligibility

All sexes

Study type

Observational

Primary location

KKRN Katholisches Klinikum Ruhrgebiet Nord GmbH (KKRN)

Dorsten, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

need for intravenous access

Exclusion criteria

n. a.

Treatment and study plan

Primary outcomes

Frequency and time of occurence of blood leakage

Time frame: Within one minute

Secondary outcomes

Problems during catheter insertion and fixation of Introcan Safety 3

Time frame: During insertion and fixation of catheter
Necessity of disconnection of catheter

Time frame: During catheter placement

Sponsors and collaborators

Lead sponsor

B. Braun Melsungen AG

Industry

Registry information

Important dates

Study start: 2012
Primary completion: 2012
Study completion: 2012
First posted: Jul 22, 2014
Registry last updated: Aug 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.